PONOI CAPITAL, LP

10% owner at IMMUNE DESIGN CORP. · on record since Oct 30, 2017
10% owner at Arcus Biosciences, Inc. · on record since Mar 19, 2018
10% owner at CONSTAR INTERNATIONAL INC · on record since Jul 23, 2018
10% owner at NGM BIOPHARMACEUTICALS INC · on record since Jun 26, 2019
Director at NGM BIOPHARMACEUTICALS INC · on record since May 22, 2019
10% owner at RAPTOR TECHNOLOGY GROUP, INC. · on record since Oct 30, 2019
10% owner at Revolution Medicines, Inc. · on record since Feb 18, 2020
10% owner at Nurix Therapeutics, Inc. · on record since Jul 29, 2020

Insider trading activity of PONOI CAPITAL, LP

Transactions on record: 9; since Feb 28, 2020

Open-market buys: 9; $3M

Open-market sells: 0

Companies traded: 1; last filing May 23, 2022

Figures computed from official regulatory filings — .

Companies where PONOI CAPITAL, LP has traded

NGM BIOPHARMACEUTICALS INC9 tx · $3M · May 23, 2022

Track record of PONOI CAPITAL, LP

Open-market buys: 9

Last buy: May 20, 2022

Enough buys on record, but none of them has a 63-day return yet — this happens when the shares stopped trading, or when the buys are too recent. Win rates will appear once returns mature.

Transaction history of PONOI CAPITAL, LP

Co-insiders of PONOI CAPITAL, LP

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
NGM BIOPHARMACEUTICALS INCListing unverified	May 23, 2022	Buy	18,406	13.48 USD	$248.1K	conv 29Cluster	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	May 23, 2022	Buy	682	13.25 USD	$9K	conv 41ClusterFirst in 12mo	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	May 23, 2022	Buy	19,984	13.25 USD	$264.8K	conv 41ClusterFirst in 12mo	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	May 23, 2022	Buy	628	13.48 USD	$8.5K	conv 29Cluster	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Sep 3, 2020	Buy	27,595	17.67 USD	$487.6K	conv 29Cluster	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Sep 3, 2020	Buy	36,494	17.64 USD	$643.8K	conv 40Cluster	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Feb 28, 2020	Buy	3,751	18.00 USD	$67.5K	conv 46ClusterFirst in 12mo	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Feb 28, 2020	Buy	37,800	17.91 USD	$677K	conv 43Cluster	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Feb 28, 2020	Buy	33,896	17.91 USD	$607.1K	conv 43Cluster	SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
NGM BIOPHARMACEUTICALS INCListing unverified	May 23, 2022	Buy	18,406	13.48 USD	$248.1K	conv 29Cluster	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	May 23, 2022	Buy	682	13.25 USD	$9K	conv 41ClusterFirst in 12mo	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	May 23, 2022	Buy	19,984	13.25 USD	$264.8K	conv 41ClusterFirst in 12mo	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	May 23, 2022	Buy	628	13.48 USD	$8.5K	conv 29Cluster	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Sep 3, 2020	Buy	27,595	17.67 USD	$487.6K	conv 29Cluster	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Sep 3, 2020	Buy	36,494	17.64 USD	$643.8K	conv 40Cluster	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Feb 28, 2020	Buy	3,751	18.00 USD	$67.5K	conv 46ClusterFirst in 12mo	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Feb 28, 2020	Buy	37,800	17.91 USD	$677K	conv 43Cluster	SEC
NGM BIOPHARMACEUTICALS INCListing unverified	Feb 28, 2020	Buy	33,896	17.91 USD	$607.1K	conv 43Cluster	SEC